Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023

Upgrades

According to RBC Capital, the prior rating for Montrose Environmental Group Inc (NYSE:MEG) was changed from Sector Perform to Outperform. In the second quarter, Montrose Environmental Gr showed an EPS of $0.13, compared to $0.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $55.00 and a 52-week-low of $26.64. Montrose Environmental Gr closed at $27.76 at the end of the last trading period.

For Ameris Bancorp (NASDAQ:ABCB), DA Davidson upgraded the previous rating of Neutral to Buy. For the second quarter, Ameris had an EPS of $0.91, compared to year-ago quarter EPS of $1.18. The stock has a 52-week-high of $54.17 and a 52-week-low of $28.33. At the end of the last trading period, Ameris closed at $38.22.

According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ:SBRA) was changed from Neutral to Buy. For the second quarter, Sabra Health Care REIT had an EPS of $0.33, compared to year-ago quarter EPS of $0.39. At the moment, the stock has a 52-week-high of $14.32 and a 52-week-low of $10.08. Sabra Health Care REIT closed at $14.01 at the end of the last trading period.

According to B of A Securities, the prior rating for Omega Healthcare Investors Inc (NYSE:OHI) was changed from Neutral to Buy. Omega Healthcare Invts earned $0.74 in the second quarter, compared to $0.76 in the year-ago quarter. The stock has a 52-week-high of $34.13 and a 52-week-low of $25.61. At the end of the last trading period, Omega Healthcare Invts closed at $33.64.

B of A Securities upgraded the previous rating for Electronic Arts Inc (NASDAQ:EA) from Neutral to Buy. For the first quarter, Electronic Arts had an EPS of $1.14, compared to year-ago quarter EPS of $0.47. The current stock performance of Electronic Arts shows a 52-week-high of $140.30 and a 52-week-low of $108.53. Moreover, at the end of the last trading period, the closing price was at $124.59.

Piper Sandler upgraded the previous rating for Exact Sciences Corp (NASDAQ:EXAS) from Neutral to Overweight. In the second quarter, Exact Sciences showed an EPS of $0.45, compared to $0.90 from the year-ago quarter. The stock has a 52-week-high of $100.77 and a 52-week-low of $29.29. At the end of the last trading period, Exact Sciences closed at $64.46.

Jefferies upgraded the previous rating for Pinnacle Financial Partners Inc (NASDAQ:PNFP) from Underperform to Hold. In the second quarter, Pinnacle Finl Partners showed an EPS of $1.79, compared to $1.86 from the year-ago quarter. The stock has a 52-week-high of $89.00 and a 52-week-low of $43.31. At the end of the last trading period, Pinnacle Finl Partners closed at $66.25.

For ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), JP Morgan upgraded the previous rating of Neutral to Overweight. In the second quarter, ACADIA Pharmaceuticals showed an EPS of $0.01, compared to $0.21 from the year-ago quarter. The current stock performance of ACADIA Pharmaceuticals shows a 52-week-high of $33.99 and a 52-week-low of $13.73. Moreover, at the end of the last trading period, the closing price was at $21.74.

According to UBS, the prior rating for Rivian Automotive Inc (NASDAQ:RIVN) was changed from Neutral to Buy. In the second quarter, Rivian Automotive showed an EPS of $1.08, compared to $1.62 from the year-ago quarter. At the moment, the stock has a 52-week-high of $36.44 and a 52-week-low of $11.68. Rivian Automotive closed at $18.78 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

According to Barrington Research, the prior rating for StarTek Inc (NYSE:SRT) was changed from Outperform to Market Perform. For the second quarter, StarTek had an EPS of $0.04, compared to year-ago quarter EPS of $0.13. The current stock performance of StarTek shows a 52-week-high of $4.53 and a 52-week-low of $2.64. Moreover, at the end of the last trading period, the closing price was at $3.26.

For Netstreit Corp (NYSE:NTST), B of A Securities downgraded the previous rating of Neutral to Underperform. In the second quarter, Netstreit showed an EPS of $0.30, compared to $0.28 from the year-ago quarter. The current stock performance of Netstreit shows a 52-week-high of $20.64 and a 52-week-low of $14.84. Moreover, at the end of the last trading period, the closing price was at $15.20.

For Spirit Realty Capital Inc (NYSE:SRC), B of A Securities downgraded the previous rating of Neutral to Underperform. Spirit Realty Cap earned $0.91 in the second quarter, compared to $0.90 in the year-ago quarter. The stock has a 52-week-high of $44.65 and a 52-week-low of $32.48. At the end of the last trading period, Spirit Realty Cap closed at $33.59.

For Realty Income Corp (NYSE:O), B of A Securities downgraded the previous rating of Buy to Neutral. For the second quarter, Realty Income had an EPS of $1.00, compared to year-ago quarter EPS of $0.97. The stock has a 52-week-high of $68.85 and a 52-week-low of $48.41. At the end of the last trading period, Realty Income closed at $50.55.

According to Citigroup, the prior rating for Skyworks Solutions Inc (NASDAQ:SWKS) was changed from Neutral to Sell. Skyworks Solutions earned $1.73 in the third quarter, compared to $2.44 in the year-ago quarter. The stock has a 52-week-high of $123.69 and a 52-week-low of $76.17. At the end of the last trading period, Skyworks Solutions closed at $98.22.

According to Citigroup, the prior rating for Qorvo Inc (NASDAQ:QRVO) was changed from Neutral to Sell. For the first quarter, Qorvo had an EPS of $0.34, compared to year-ago quarter EPS of $2.25. The current stock performance of Qorvo shows a 52-week-high of $114.59 and a 52-week-low of $75.58. Moreover, at the end of the last trading period, the closing price was at $94.90.

UBS downgraded the previous rating for NextEra Energy Partners LP (NYSE:NEP) from Buy to Neutral. NextEra Energy Partners earned $0.53 in the second quarter, compared to $2.61 in the year-ago quarter. The stock has a 52-week-high of $81.07 and a 52-week-low of $20.17. At the end of the last trading period, NextEra Energy Partners closed at $20.58.

For Euronav NV (NYSE:EURN), Citigroup downgraded the previous rating of Buy to Neutral. For the second quarter, Euronav had an EPS of $0.80, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $21.00 and a 52-week-low of $12.94. At the end of the last trading period, Euronav closed at $17.69.

Piper Sandler downgraded the previous rating for Mirati Therapeutics Inc (NASDAQ:MRTX) from Overweight to Neutral. For the second quarter, Mirati Therapeutics had an EPS of $3.04, compared to year-ago quarter EPS of $3.18. The stock has a 52-week-high of $101.20 and a 52-week-low of $27.30. At the end of the last trading period, Mirati Therapeutics closed at $57.02.

Stifel downgraded the previous rating for Euronav NV (NYSE:EURN) from Buy to Hold. In the second quarter, Euronav showed an EPS of $0.80, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $21.00 and a 52-week-low of $12.94. Euronav closed at $17.69 at the end of the last trading period.

According to JP Morgan, the prior rating for Juniper Networks Inc (NYSE:JNPR) was changed from Overweight to Neutral. For the second quarter, Juniper Networks had an EPS of $0.58, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $34.53 and a 52-week-low of $25.18. At the end of the last trading period, Juniper Networks closed at $26.82.

According to Keefe, Bruyette & Woods, the prior rating for Starwood Property Trust Inc (NYSE:STWD) was changed from Outperform to Market Perform. In the second quarter, Starwood Prop Trust showed an EPS of $0.49, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $21.73 and a 52-week-low of $16.06. At the end of the last trading period, Starwood Prop Trust closed at $19.05.

JP Morgan downgraded the previous rating for Corning Inc (NYSE:GLW) from Overweight to Neutral. Corning earned $0.45 in the second quarter, compared to $0.57 in the year-ago quarter. The current stock performance of Corning shows a 52-week-high of $37.10 and a 52-week-low of $29.17. Moreover, at the end of the last trading period, the closing price was at $29.44.

See all analyst ratings downgrades.

Initiations

With a Buy rating, Ladenburg Thalmann initiated coverage on Zura Bio Ltd (NASDAQ:ZURA). The price target seems to have been set at $10.00 for Zura Bio. Zura Bio earned $1.31 in the second quarter, compared to $9.54 in the year-ago quarter. The current stock performance of Zura Bio shows a 52-week-high of $37.55 and a 52-week-low of $4.87. Moreover, at the end of the last trading period, the closing price was at $6.93.

With an Overweight rating, JP Morgan initiated coverage on Neumora Therapeutics Inc (NASDAQ:NMRA). The price target seems to have been set at $21.00 for Neumora Therapeutics. At the moment, the stock has a 52-week-high of $17.74 and a 52-week-low of $9.90. Neumora Therapeutics closed at $11.94 at the end of the last trading period.

Scotiabank initiated coverage on MongoDB Inc (NASDAQ:MDB) with a Sector Perform rating. The price target for MongoDB is set to $335.00. In the second quarter, MongoDB showed an EPS of $0.93, compared to $0.23 from the year-ago quarter. The current stock performance of MongoDB shows a 52-week-high of $439.00 and a 52-week-low of $135.17. Moreover, at the end of the last trading period, the closing price was at $358.31.

Truist Securities initiated coverage on Blackstone Secured Lending Fund (NYSE:BXSL) with a Buy rating. The price target for Blackstone Secured is set to $29.00. For the second quarter, Blackstone Secured had an EPS of $1.06, compared to year-ago quarter EPS of $0.62. At the moment, the stock has a 52-week-high of $29.11 and a 52-week-low of $22.08. Blackstone Secured closed at $26.43 at the end of the last trading period.

With a Buy rating, B of A Securities initiated coverage on Neumora Therapeutics Inc (NASDAQ:NMRA). The price target seems to have been set at $18.00 for Neumora Therapeutics. At the moment, the stock has a 52-week-high of $17.74 and a 52-week-low of $9.90. Neumora Therapeutics closed at $11.94 at the end of the last trading period.

With a Buy rating, Truist Securities initiated coverage on RayzeBio inc (NASDAQ:RYZB). The price target seems to have been set at $29.00 for RayzeBio. The stock has a 52-week-high of $26.00 and a 52-week-low of $17.95. At the end of the last trading period, RayzeBio closed at $21.03.

With a Neutral rating, B of A Securities initiated coverage on Popular Inc (NASDAQ:BPOP). The price target seems to have been set at $63.00 for Popular. In the second quarter, Popular showed an EPS of $2.10, compared to $2.77 from the year-ago quarter. The current stock performance of Popular shows a 52-week-high of $77.36 and a 52-week-low of $49.34. Moreover, at the end of the last trading period, the closing price was at $64.13.

With a Neutral rating, Compass Point initiated coverage on Equity Lifestyle Properties Inc (NYSE:ELS). The price target seems to have been set at $65.00 for Equity Lifestyle Props. Equity Lifestyle Props earned $0.66 in the second quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $74.40 and a 52-week-low of $57.01. Equity Lifestyle Props closed at $64.03 at the end of the last trading period.

Exane BNP Paribas initiated coverage on Dollar General Corp (NYSE:DG) with a Neutral rating. The price target for Dollar Gen is set to $116.00. In the second quarter, Dollar Gen showed an EPS of $2.13, compared to $2.98 from the year-ago quarter. The current stock performance of Dollar Gen shows a 52-week-high of $261.57 and a 52-week-low of $101.98. Moreover, at the end of the last trading period, the closing price was at $102.00.

Exane BNP Paribas initiated coverage on Dollar Tree Inc (NASDAQ:DLTR) with an Outperform rating. The price target for Dollar Tree is set to $139.00. In the second quarter, Dollar Tree showed an EPS of $0.91, compared to $1.60 from the year-ago quarter. The stock has a 52-week-high of $170.36 and a 52-week-low of $102.77. At the end of the last trading period, Dollar Tree closed at $104.71.

For Neumora Therapeutics Inc (NASDAQ:NMRA), William Blair initiated coverage, by setting the current rating at Outperform. The stock has a 52-week-high of $17.74 and a 52-week-low of $9.90. At the end of the last trading period, Neumora Therapeutics closed at $11.94.

With a Buy rating, Daiwa Capital initiated coverage on ARM Holdings PLC (NASDAQ:ARM). The price target seems to have been set at $63.00 for ARM Holdings. The stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. At the end of the last trading period, ARM Holdings closed at $54.25.

With a Buy rating, Guggenheim initiated coverage on Neumora Therapeutics Inc (NASDAQ:NMRA). The price target seems to have been set at $22.00 for Neumora Therapeutics. The current stock performance of Neumora Therapeutics shows a 52-week-high of $17.74 and a 52-week-low of $9.90. Moreover, at the end of the last trading period, the closing price was at $11.94.

With an Outperform rating, RBC Capital initiated coverage on Neumora Therapeutics Inc (NASDAQ:NMRA). The price target seems to have been set at $24.00 for Neumora Therapeutics. The stock has a 52-week-high of $17.74 and a 52-week-low of $9.90. At the end of the last trading period, Neumora Therapeutics closed at $11.94.

JP Morgan initiated coverage on RayzeBio inc (NASDAQ:RYZB) with an Overweight rating. The price target for RayzeBio is set to $30.00. The stock has a 52-week-high of $26.00 and a 52-week-low of $17.95. At the end of the last trading period, RayzeBio closed at $21.03.

With a Buy rating, Jefferies initiated coverage on RayzeBio inc (NASDAQ:RYZB). The price target seems to have been set at $35.00 for RayzeBio. The stock has a 52-week-high of $26.00 and a 52-week-low of $17.95. At the end of the last trading period, RayzeBio closed at $21.03.

Stifel initiated coverage on Neumora Therapeutics Inc (NASDAQ:NMRA) with a Buy rating. The price target for Neumora Therapeutics is set to $26.00. The stock has a 52-week-high of $17.74 and a 52-week-low of $9.90. At the end of the last trading period, Neumora Therapeutics closed at $11.94.

With a Buy rating, Societe Generale initiated coverage on SLB (NYSE:SLB). The price target seems to have been set at $81.00 for SLB. SLB earned $0.72 in the second quarter, compared to $0.50 in the year-ago quarter. The current stock performance of SLB shows a 52-week-high of $62.78 and a 52-week-low of $41.10. Moreover, at the end of the last trading period, the closing price was at $58.24.

With an Outperform rating, Wedbush initiated coverage on MannKind Corp (NASDAQ:MNKD). The price target seems to have been set at $10.00 for MannKind. For the second quarter, MannKind had an EPS of $0.00, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $5.75 and a 52-week-low of $2.91. At the end of the last trading period, MannKind closed at $3.94.

With a Market Perform rating, TD Cowen initiated coverage on Advance Auto Parts Inc (NYSE:AAP). The price target seems to have been set at $55.00 for Advance Auto Parts. Advance Auto Parts earned $1.43 in the second quarter, compared to $3.74 in the year-ago quarter. The stock has a 52-week-high of $194.23 and a 52-week-low of $50.14. At the end of the last trading period, Advance Auto Parts closed at $51.36.

TD Cowen initiated coverage on AutoZone Inc (NYSE:AZO) with an Outperform rating. The price target for AutoZone is set to $2975.00. In the fourth quarter, AutoZone showed an EPS of $46.46, compared to $40.51 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2750.00 and a 52-week-low of $2165.93. AutoZone closed at $2564.93 at the end of the last trading period.

TD Cowen initiated coverage on O'Reilly Automotive Inc (NASDAQ:ORLY) with an Outperform rating. The price target for O'Reilly Automotive is set to $1100.00. For the second quarter, O'Reilly Automotive had an EPS of $10.22, compared to year-ago quarter EPS of $8.78. At the moment, the stock has a 52-week-high of $975.72 and a 52-week-low of $705.74. O'Reilly Automotive closed at $914.67 at the end of the last trading period.

See all analyst ratings initiations.